Condition: Immune Thrombocytopenia · Sponsor: Sanofi
This is a multinational, open label, single arm study that will evaluate the impact of early multi-immune modulation with rilzabrutinib in adult ITP patients who failed first-line treatment. The study includes a screening period (up to 8 weeks), a primary analysis period (up to 28 weeks), a long-term extension period for selected participants (28 weeks) and a 24-week follow-up period only for eligible participants.
This description comes directly from the study's public registry record.
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · contact-us@sanofi.com
Always discuss trial participation with your own doctor first.
| Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates) | Clovis, California, United States | Recruiting |
| University of Southern California (USC) | Los Angeles, California, United States | Recruiting |
| Tulane University Health Sciences Center - Tulane Avenue-Investigational Site Number: 8400011 | New Orleans, Louisiana, United States | Recruiting |
| Massachusetts General Hospital Cancer Center | Boston, Massachusetts, United States | Recruiting |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | Recruiting |
| Mass General Brigham Cancer Institute | Danvers, Massachusetts, United States | Recruiting |
| University of Michigan Health - Michigan Medicine - University Hospital-Investigational Site Number: 8400001 | Ann Arbor, Michigan, United States | Recruiting |
| Mayo Clinic_Investigational Site Number: 8400009 | Rochester, Minnesota, United States | Recruiting |
| New York Oncology Hematology-Investigational Site Number: 8400010 | Albany, New York, United States | Recruiting |
| Montefiore Medical Center-Investigational Site Number: 8400012 | The Bronx, New York, United States | Recruiting |
| Oregon Health and Sciences University | Portland, Oregon, United States | Recruiting |
| Community Cancer Trials of Utah-Investigational Site Number: 8400002 | Ogden, Utah, United States | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07007962